Claude Code · Anthropic · Demis Hassabis · OpenAI · Claude · Sam Altman · MIT Technology Review
CEO Demis Hassabis and researcher John Jumper won the Nobel Prize in chemistry for their work on the company’s AlphaFold
Compiled by KHAO Editorial — aggregated from 2 sources. See llms.txt for citation guidance.
◎ Multiple-sources
Anthropic is well positioned to take up DeepMind’s scientific mantle.
Key facts
- Like Hassabis, Anthropic CEO Dario Amodei is a PhD scientist—unlike OpenAI CEO Sam Altman, who’s a businessman
- According to Kauderer-Abrams, Claude Science isn’t intended to displace Claude Code and Claude Cowork in scientists’ workflows
- Anthropic’s decision to elevate Claude Science to the same rank as Claude Code and Claude Cowork indicates that the company is taking AI’s scientific applications seriously—or at least wants to give
- CEO Demis Hassabis and researcher John Jumper won the Nobel Prize in chemistry for their work on the company’s AlphaFold model, and DeepMind has also made major contributions to meteorology
Summary
At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, a major new product intended to support scientific research in the same way that Claude Code supports software engineering. This is not Anthropic’s first foray into AI for science. “It represents how important this is to our mission that this is right up there with Claude Code and Claude Cowork as the next significant product that we’re releasing,” says Eric Kauderer-Abrams, Anthropic’s head of life sciences. For the past decade, one company—Google DeepMind—has been at the vanguard of AI for science. Like Hassabis, Anthropic CEO Dario Amodei is a PhD scientist—unlike OpenAI CEO Sam Altman, who’s a businessman through and through.